Published on: 2025-07-05 00:12:09
There's a new way to screen for early detection of Alzheimer's disease. On Friday, the Food and Drug Administration (FDA) cleared the first blood test for the disorder. Fujirebio Diagnostics' Lumipulse measures the ratio of two proteins that correlate with the presence or absence of Alzheimer's. Previously, patients being screened for Alzheimer's were limited to more invasive options: a PET Scan or spinal tap. Lumipulse is intended for use in clinical settings with patients exhibiting signs of
Keywords: alzheimer amyloid negative results test
Find related items on AmazonPublished on: 2025-07-22 17:00:04
If you had the opportunity to know your odds of developing Alzheimer’s in the not-too-distant future, would you take it? And how might the knowledge change you? Research this week is among the first to try answering that second question. Scientists in Israel and the U.S. conducted the study, which surveyed hundreds of people before and after they received a Positron Emission Tomography (PET) scan to assess their Alzheimer’s risk status. Regardless of whether they tested positive or negative for
Keywords: alzheimer amyloid healthy people risk
Find related items on AmazonPublished on: 2025-08-07 09:19:27
Article Content A new study found that a gene recently recognized as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown secondary function. Researchers at the University of California San Diego used artificial intelligence to help both unravel this mystery of Alzheimer’s disease and discover a potential treatment that obstructs the gene’s moonlighting role. The research team published their results on April 23 in the journal Cell. About one in nine pe
Keywords: alzheimer disease gene phgdh researchers
Find related items on AmazonPublished on: 2025-08-29 20:43:59
SEATTLE — Andrea Gilbert thought she knew what would happen to her brain. The 79-year-old retired attorney, who has Alzheimer’s disease and receives care at Harborview Medical Center in Seattle, agreed to donate it for research in 2023. She hoped to help scientists unlock the keys to a disease that had left her writing notes to remind herself if she’d already brushed her teeth. The fate of that program is now in limbo because the Trump administration has upended the system that funds biomedica
Keywords: alzheimer disease gilbert research said
Find related items on AmazonPublished on: 2025-10-07 15:30:47
We might be on the precipice of a pivotal moment in Alzheimer’s disease research. In clinical trial data released this week, scientists have presented early evidence that it’s possible to delay symptoms in people genetically fated to develop Alzheimer’s at a young age. Researchers at the Washington University School of Medicine led the study, which aimed to test whether an experimental anti-amyloid drug called gantenerumab could help people with an inherited form of Alzheimer’s. In a subset of
Keywords: alzheimer amyloid patients people study
Find related items on AmazonGo K’awiil is a project by nerdhub.co that curates technology news from a variety of trusted sources. We built this site because, although news aggregation is incredibly useful, many platforms are cluttered with intrusive ads and heavy JavaScript that can make mobile browsing a hassle. By hand-selecting our favorite tech news outlets, we’ve created a cleaner, more mobile-friendly experience.
Your privacy is important to us. Go K’awiil does not use analytics tools such as Facebook Pixel or Google Analytics. The only tracking occurs through affiliate links to amazon.com, which are tagged with our Amazon affiliate code, helping us earn a small commission.
We are not currently offering ad space. However, if you’re interested in advertising with us, please get in touch at [email protected] and we’ll be happy to review your submission.